Dopamine D 1 /D 5 receptor antagonism has been shown to block the euphoric and stimulatory effects of cocaine in humans and rats. In the present study, rats trained to discriminate the presence of cocaine (10 mg/kg) from its absence were used to analyze the functional contribution of D 1 (D 1 R) versus D 5 (D 5 R) receptors in the nucleus accumbens, an important neural site for the actions of cocaine. Bilateral microinfusion into the nucleus accumbens of an antisense oligonucleotide directed at the D 5 R (0.75 nmol/0.3 l per side, two times per day for 3 d) elicited a downward shift in the dose-effect curve for cocaine with a suppression of peak efficacy; the dose of cocaine estimated to elicit 50% drug-lever responding (ED 50 ) was 6.71 mg/kg when assessed 12 hr after the D 5 R antisense oligonucleotide compared to the control ED 50 of 1.83 mg/kg and to the ED 50 of 1.75 mg/kg established 7 d after the last D 5 R antisense oligonucleotide infusion. The D 1 R antisense and scrambled oligonucleotide (0.75 nmol/0.3 l per side, two times per day for 3 d) were both ineffective. Thus, using drug discrimination techniques that model the subjective effects of cocaine, we show that responsiveness to cocaine is dramatically attenuated after interference with the process of translation of the D 5 R mRNA to its protein product. These findings suggest that D 5 R is a functionally important target site for the indirect actions of cocaine and that rigorous investigations of the function of D 5 R may help guide the discovery of strategies for pharmacotherapy in cocaine dependence.
Cocaine abuse continues to impose serious medical, psychological, and criminal challenges for society. A thorough understanding of the neural basis underlying the effects of cocaine is critical to the development of science-based treatment protocols for cocaine dependence. One primary target for the actions of cocaine is the mesocorticolimbic dopamine circuit (Callahan et al., 1997; McBride et al., 1999) , which has been implicated in reward, emotional, and motivational processes, as well as in psychosis and mania (Kalivas and Nemeroff, 1988) . Dopamine acts at D 1 -and D 2 -like receptors, each of which is comprised of at least two receptor subtypes. The D 1 -like receptor family includes the D 1 receptor (D 1 R; also known as D1a) and D 5 receptor (D 5 R; also known as D1b), which are separate gene products, exhibiting differential anatomical localization, but pharmacologically indiscriminable transduction pathways and agonist/antagonist profiles (Baldessarini and Tarazi, 1996) . Oral administration of the D 1 R/D 5 R antagonist ecopipam (SCH 39166) was shown to significantly attenuate the euphoric and stimulatory effects of cocaine in humans (Romach et al., 1999) . This recent observation in humans is consistent with findings that systemic administration of the D 1 R/D 5 R antagonist SCH 23390 blocked the locomotor stimulant, discriminative stimulus and reinforcing effects of cocaine in rodents (Callahan et al., 1991; Caine and Koob, 1994; Tella, 1994) . In addition, intra-accumbens microinfusion of SCH 23390 completely antagonized the interoceptive (Callahan et al., 1997) and reinforcing effects of systemically administered cocaine (Caine et al., 1993; McGregor and Roberts, 1993) . However, because SCH 23390, as well as other nonselective D 1 -like receptor antagonists, has almost equal affinity for D 1 R and D 5 R, the contribution of each receptor subtype to the behavioral effects of cocaine has received little attention. In fact, because of the lack of selective ligands, the relative functional contributions of the D 1 R versus D 5 R remain uncharacterized in vivo. With the cloning of both the D 1 R and D 5 R genes (Monsma et al., 1990; Sunahara et al., 1991) , the application of molecular biological tools to this question has been possible, in the forms of analysis of D 1 R knock-out mice (Xu et al., 1994) and the use of antisense oligonucleotides directed at the translation initiation sequences of the rat D 1 R and D 5 R genes Dziewczapolski et al., 1998) .
In the present study, we used the drug discrimination technique as a rodent model of the subjective effects of cocaine in humans (Schuster and Johanson, 1988; Drummond et al., 1995) . In this assay, saline or cocaine (10 mg/kg) is injected and the rat must press one of two levers in the operant chamber to obtain a water reinforcer based on the recognition of the preceding injection. For example, when completion of the fixed ratio of 20 presses on the cocaine-associated lever follows the cocaine injection, the animal is "correct", and a water reinforcer is delivered. On saline sessions, completion of a fixed ratio of 20 presses on the salineappropriate lever is reinforced with water. To analyze the relative role of D 1 R versus D 5 R in the discriminative stimulus effects of cocaine (10 mg/kg), a cumulative dose-response relationship (Schechter, 1997) for cocaine was established before and after microinfusion of antisense oligonucleotides directed at either D 1 R or D 5 R mRNA into the shell of the nucleus accumbens, which has been shown to be particularly sensitive to the actions of cocaine (Pontieri et al., 1995; McBride et al., 1999) . We found that a selective and reversible loss of recognition of cocaine resulted from intra-nucleus accumbens pretreatment with the D 5 R (but not D 1 R) antisense oligonucleotide.
Parts of this paper have been published previously at the 61st annual meeting of the College on Problems of Drug Dependence (Acapulco, Mexico, 1999) .
MATERIALS AND METHODS
Animals. Adult male Sprague Dawley rats (n ϭ 34; Harlan, Houston, TX) weighing between 300 and 350 gm at the beginning of the study were used. The rats were housed in pairs in a colony room that was maintained at a constant temperature (21-23°C) and humidity (40 -50%); lighting was maintained on a 12 hr light /dark cycle (7:00 A.M.-7:00 P.M.). The amount of water each animal received during drug discrimination studies was restricted to that given during operant training sessions, after test sessions (10 -15 min), and on weekends (36 hr). All experiments were conducted during the light phase (between 9:00 A.M. and 3:00 P.M.). All experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laborator y Animals.
Apparatus. The procedures were conducted in commercially available, two-lever operant chambers (model 80001; Lafayette Instrument, Lafayette, I N). Each chamber, housed in a light-and sound-attenuating cubicle (model 80015; Lafayette Instrument), was equipped with a water-filled dispenser mounted equidistant between two response levers on one wall. A 28 V house light provided illumination, and a blower supplied ventilation and masking noise. An interface (MedAssociates, St. Albans, V T) connected the chambers to a computer that controlled and recorded all experimental events.
Procedures. Standard two-lever, water-reinforced drug discrimination procedures were used (Cunningham et al., 1985) . Rats were injected intraperitoneally with cocaine (10 mg / kg) or saline (1 ml / kg) 15 min before daily sessions. During this phase, only the stimulus-appropriate (drug or saline) lever was present. Training began under a fixed ratio 1 (FR 1) schedule of water reinforcement, and the FR requirement was incremented until all animals were responding reliably under an FR 20 schedule for each experimental condition. Both levers were then presented simultaneously, and rats were required to respond on the stimulus-appropriate lever to obtain reinforcement ("discrimination" training).
Test protocols. When rats demonstrated individual accuracies of at least 80% correct responses before the first reinforcer for 10 consecutive sessions, test sessions were initiated, and training sessions were run during the intervening days to maintain discrimination accuracy. Because only a narrow time frame was available in which to assess oligonucleotide-evoked alterations, we used a cumulative dose -response procedure (Schechter, 1997) . The series began with an injection of saline and introduction to the operant chamber 10 min later. After completion of 20 responses on either lever (occurring within a few seconds), a single reinforcer was delivered, and the house lights were turned off; as the rat was removed from the chamber, the first dose of cocaine (0.625 mg / kg) was administered. Access to the operant chamber occurred 10 min later, and rats were again removed after accumulation of 20 responses on either lever. The series continued with another injection of cocaine (0.625 mg / kg) and testing; thus, the sequential cocaine dosing schedule was 0 (saline), 0.625, 0.625, 1.25, 2.5, and 5 mg / kg tested at 10 min intervals to achieve doses of 0, 0.625, 1.25, 2.5, 5, and 10 mg / kg of cocaine. The dose -response curve for cocaine established using the cumulative dosing procedure did not differ from that initially determined (after acquisition) with bolus injections of cocaine (0.625, 1.25, 2.5, 5, or 10 mg / kg) administered 15 min before rats were tested for lever selection (data not shown) (C allahan et al., 1991) . After testing, the rats were returned to the colony and allowed ad libitum access to water for 10 min beginning 30 min after the end of each test.
Surger y and cannulae implantation. Rats were anesthetized with an intramuscular injection of 8.6 mg / kg of xylazine, 1.5 mg / kg of acepromazine, and 43 mg / kg of ketamine in physiological saline (0.9% NaC l). Bilateral guide cannulae (26 gauge) were stereotaxically implanted 2 mm above the nucleus accumbens shell (anteroposterior, Ϫ1.7 mm from bregma; mediolateral, Ϯ0.75 mm; dorsoventral, Ϫ6 mm) (Paxinos and Watson, 1998) . After surgery, animals were injected twice with penicillin (10,000 U/ kg, i.m.) and were allowed a 1 week recovery period during which each rat was handled and weighed daily.
Microinf usion protocols. After recovery, discrimination training was reinstated for several weeks, and the cumulative dose -response curve for cocaine was reestablished and did not differ from that established before surgery (data not shown); the postsurgical dose -response curve served as control in the present experiment. During that period, rats were handled for 10 -15 min each day for 5 d to familiarize them with the microinf usion procedure. Intracranial inf usions (0.75 nmol /0.3 l per side, two times per day for 3 d) were administered through 33 gauge internal cannulae that extended 2 mm below the tips of guide cannulae into the shell of the nucleus accumbens. The injection volume of 0.3 l per side was inf used over a 3 min period at 0.1 l per min using a micropump (HoneyBee Pump; BAS, West Lafayette, I N). Injection cannulae remained in place for an additional 1 min to allow for diff usion away from the cannulae tips. T welve hours and 7 d after the intracranial inf usion procedure was completed, the cumulative dose -response curve for cocaine was reestablished. At the completion of the study, rats were killed by an overdose of chloral hydrate (800 mg / kg, i.p.), and tissue sections were processed for localization of cannulae. Only those animals whose cannulae were within the shell of the nucleus accumbens were included for statistical analysis (D 1 R rats, n ϭ 7; D 5 R rats, n ϭ 8; SCR rats, n ϭ 8). No significant tissue damage was evident after histological examination of sections.
Drugs. Cocaine HC l (National Institute of Drug Abuse, Rockville, MD) was dissolved in saline (0.9% NaC l). Antisense oligonucleotides (Life Technologies, Gaithersburg, MD) were designed against the translation initiation sequences of the rat D 1 R (5Ј-TAGGAGCCATCTTCCAG-3Ј) and D 5 R sequences (5Ј-CAGCATGTCGCGCTGAGT-3Ј). A scrambled oligonucleotide (SCR; 5Ј-ATAC TTCACGCCGATGG-3Ј) was designed that had thermodynamic properties similar to these antisense oligonucleotides. Based on a FastA search of GenBank, these oligonucleotides did not have significant homologies with any relevant, known cDNA sequences. The HPLC-purified oligonucleotides were dissolved in sterile saline.
Statistical anal yses. Performance in the drug discrimination task was expressed as the percentage of drug-appropriate responses to total responses before delivery of the first reinforcer, and the response rate was calculated as the total number of responses on either lever divided by the number of minutes taken to complete the FR 20. Only data from animals that completed the FR 20 during the test sessions were used. A two-way ANOVA for repeated measures was used to analyze the effects of oligonucleotide pretreatment and cocaine dose on the percentage of drug-lever responding and response rate. Because treatments with D 1 R antisense and scrambled oligonucleotide were not associated with any significant main effects or interactions, the results of these ANOVAs are not presented. The methods of Litchfield and Wilcoxon (1949) were used to estimate the dose of cocaine predicted to elicit 50% cocaineappropriate responding (ED 50 ) and its 95% confidence intervals (Tallarida and Murray, 1986) .
RESULTS
Assessment of the dose-effect curve for cocaine 12 hr after the last injection of the antisense oligonucleotide targeted to the D 5 R (0.75 nmol/0.3 l per side, two times daily for 3 d) indicated that the recognition of cocaine was significantly impaired (Fig. 1 B, gray squares) in comparison to the control dose-effect curve for cocaine ( Fig. 1 B, open circles) . Two-way ANOVA indicated a significant effect of treatment (F (2,21) ϭ 3.94; p ϭ 0.035), dose (F (5,105) ϭ 34.3; p ϭ 0.001) and a significant treatment ϫ dose interaction on cocaine-lever responding (F (10,105) ϭ 3.07; p ϭ 0.002); no significant differences were observed for the response rate measure. A complete recovery was observed as shown by the fact that the cumulative dose-effect curve for cocaine assessed 7 d after the termination of the D 5 R antisense oligonucleotide treatment (Fig. 1 B, filled triangles) did not differ from the control dose-effect curve. The cocaine dose estimated to elicit 50% drug-lever responding (ED 50 ) was 6.71 mg/kg when assessed 12 hr after the D 5 R antisense oligonucleotide compared to the control ED 50 of 1.83 mg/kg and to the ED 50 established 7 d after the last D 5 R antisense oligonucleotide infusion (1.75 mg/kg; Table 1 ). The effects elicited by the D 5 R antisense oligonucleotide appear to be specific, because neither the D 1 R antisense (Fig.  1 A) nor the scrambled oligonucleotide (Fig. 1C) altered the discriminative stimulus effects of cocaine (Table 1) .
DISCUSSION
Impairment of the translation of D 5 R mRNA to its protein product in the nucleus accumbens resulted in the failure of trained rats to recognize the subjective effects of systemically administered cocaine. Our findings suggest that actions at D 5 R may underlie the efficacy of D 1 -like receptor antagonists to block the euphoric and stimulatory effects of cocaine in humans (Romach et al., 1999) and animals (Callahan et al., 1991; Caine and Koob, 1994; Tella, 1994) , particularly those effects mediated by the nucleus accumbens (Caine et al., 1993; McGregor and Roberts, 1993; Callahan et al., 1997) . However, although our findings support an important role for D 5 R in the behavioral effects of cocaine, the failure of the D 1 R antisense oligonucleotide to modify the stimulus effects of cocaine does not categorically rule out a role for D 1 R; even in the face of a knockdown of D 1 R, a population of spare D 1 R in the nucleus accumbens might be capable of maintaining normal D 1 R function.
A D 1 R antisense oligonucleotide similar to that used in the present study was shown to inhibit both grooming behavior evoked by the D 1 R-like agonist SKF 38393 in intact mice and SKF 38393-evoked rotational behavior in either mice or rats (Dziewczapolski et al., 1998) with unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal pathway. An opposite role for D 5 R in the control of locomotor activity was suggested by the recent finding that SKF 38393-evoked rotational behavior in 6-OHDA-lesioned rats was facilitated after intracerebroventricular infusion of a D 5 R antisense oligonucleotide (Dziewczapolski et al., 1998) . In the present study, an important role for the D 5 R in mediating the stimulus effects of cocaine is suggested by the selective loss of recognition of cocaine after pretreatment with the D 5 R antisense oligonucleotide into the nucleus accumbens shell and a subsequent complete recovery. We did not analyze presumed loss of D 1 R and D 5 R protein after oligonucleotide administration because of the limited availability of selective D 1 R and D 5 R antibodies and the noted lack of correlation between functional parameters and reductions in protein levels. For example, both behavioral and physiological responses have been shown to be altered after knockdown conditions in the absence of significant changes in receptor density (Wahlestedt et al., 1993; Zhou et al., 1994) . In fact, a previous study had demonstrated that D 1 R and D 5 R antisense oligonucleotide administration significantly altered behaviors evoked by the D 1 R/D 5 R agonist SKF 38393 in the absence of a detectable loss of receptor protein (Dziewczapolski et al., 1998) . In contrast, a recent analysis of D 1 R and D 5 R-like immunoreactivity in the ventral tegmental area after intraparenchymal infusion of a similar D 1 R or the identical D 5 R antisense oligonucleotide to those used here identified a significant loss of D 1 R and D 5 R protein in this region, respectively (Frye and Vongher, 1999) .
Our evidence indicates that the D 5 R in nucleus accumbens plays an important role in the actions of cocaine. The abundance of D 5 R mRNA and protein in the striatal complex of rats and primates, however, has been described as relatively low (Tiberi et al., 1991; Meador-Woodruff et al., 1992; Bergson et al., 1995; Ariano et al., 1999; Luedtke et al., 1999) . Interestingly, selective protein-protein coupling between the D 5 R and GABA A -ligandgated channel has been identified and shown to enable mutually inhibitory functional interactions in cultured hippocampal cells (Liu et al., 2000) . Such an interaction may underlie the observation that stimulation of a D 1 -like receptor modulates GABA A receptor-mediated synaptic activity in striatal neurons (Yan and Surmeier, 1997) . Furthermore, numerous recent observations suggest that GABAergic control of striatal function is integral in the neural response to cocaine administration (Gerasimov et al., 1999; Jung et al., 1999; Resnick et al., 1999) . Thus, the attenuation of cocaine-induced behavior seen after D 5 R knockdown may be amplified by an operational disruption of the coupled function between D 5 R and GABA A receptor channels, allowing the apparently limited number of D 5 R in striatal regions to play an important role in the control of behavior.
In summary, using drug discrimination techniques that model the subjective effects of cocaine, we show that responsiveness to cocaine is dramatically attenuated by knockdown of the D 5 R in the nucleus accumbens. These findings suggest that D 5 R is a functionally important target site for the indirect actions of cocaine. Based on the known parallel between the discriminative stimulus properties of cocaine in animals and its interoceptive effects in humans as well as the prominent role of interoceptive stimuli in the initiation and maintenance of drug-seeking behav- The dose (mg/kg) predicted to elicit 50% drug-lever responding and its 95% confidence intervals (CI) were calculated using the methods of Litchfield and Wilcoxon (Tallarida and Murray, 1986) .
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• Cocaine Behavior and D 5 Receptor Knockdownior (Schuster and Johanson, 1988; Drummond et al., 1995) , the present data suggest that rigorous investigations of the role of D 5 R in drug dependence and psychiatric disorders are warranted and may help guide the discovery of D 5 R-targeted strategies for effective pharmacotherapies.
